Crystal financial tombstone celebrating the initial public offering of Emcure Pharmacuticals on the Bombay Stock Exchange and National Stock Exchange. The Pune, India-based drugmaker focuses on women’s healthcare. (24AKL301)
Crystal financial tombstone celebrating the initial public offering of Emcure Pharmacuticals on the Bombay Stock Exchange and National Stock Exchange. The Pune, India-based drugmaker focuses on women’s healthcare. (24AKL301)
Crystal tombstone commemorting a private placement and a follow-on offering by Calidi Biotherapeutics. The San Diego-based company specializes in the development of cell-based therapies. (24AKL339)
Custom Lucite deal toy marking the acquisition of two royalty interest in sales of breast cancer drug Orserdu. (24AKL125)
Crystal commemorative celebrating FDA approval of Ogsiveo, a treatment for desmoid tumors. (24aZH051)
Code name-themed crystal financial tombstone commemorating a partnership between Bayer and Pairwise. The joint venture will center on gene-editing capabilities for five crops: corn, soybean, wheat, cotton, and canola. (23AJH084)
Crystal deal toy marking a debt facility provided for Ocular Therapeutix. The biopharpharmaceutical commpany specializes in the treatment of diseases of the eye, using bioresorbable hydrogel-based technology. (23AJH088)
Crystal financial tombstone commemorating a follow-on offering of stock by Intelligent Bio Solutions. The New York-based life sciences company develops non-invasive monitoring and diagnostic tests. (23AKL447)
Crystal financial tombstone commemorating a public offering of common stock by Kiora Pharmaceuticals. The California-based biotech company concentrates on developing and commercializing treatments for rare retinal diseases. (23AJH059)
Crystal tombstone celebrating a favorable verdict in an antitrust action against Gilead Sciences. The claim had centered on an earlier patent settlement involving Gilead and Teva. (23AKL380)
